97 related articles for article (PubMed ID: 19901887)
1. Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report.
Yoshino N; Kubokura H; Yamauchi S; Oaki Y; Koizumi K; Shimizu K
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):324-7. PubMed ID: 19901887
[TBL] [Abstract][Full Text] [Related]
2. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
Dorfman DM; Shahsafaei A; Chan JK
Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
[TBL] [Abstract][Full Text] [Related]
3. Expression of proteasome subunit β5t in thymic epithelial tumors.
Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M
Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
Kojika M; Ishii G; Yoshida J; Nishimura M; Hishida T; Ota SJ; Murata Y; Nagai K; Ochiai A
Mod Pathol; 2009 Oct; 22(10):1341-50. PubMed ID: 19648882
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
[TBL] [Abstract][Full Text] [Related]
6. Thymoma with ganglioneuroblastomatous component: case report.
Kashiwabara K; Ikota H; Tanaka S; Ohta C; Yajima T; Endoh H; Yamaki E; Kuwano H; Nakajima T
Virchows Arch; 2008 Mar; 452(3):319-24. PubMed ID: 18094997
[TBL] [Abstract][Full Text] [Related]
7. CD5 expression in thymic carcinoma.
Hishima T; Fukayama M; Fujisawa M; Hayashi Y; Arai K; Funata N; Koike M
Am J Pathol; 1994 Aug; 145(2):268-75. PubMed ID: 7519823
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.
Kriegsmann M; Muley T; Harms A; Tavernar L; Goldmann T; Dienemann H; Herpel E; Warth A
Diagn Pathol; 2015 Dec; 10():210. PubMed ID: 26643918
[TBL] [Abstract][Full Text] [Related]
9. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.
Pan CC; Chen PC; Chiang H
J Pathol; 2004 Mar; 202(3):375-81. PubMed ID: 14991904
[TBL] [Abstract][Full Text] [Related]
10. Ectopic hamartomatous thymoma: a case report showing CD99+ lymphocytes and a low proliferation index.
Lee SN; Cho MS; Koo H; Han WS
Arch Pathol Lab Med; 2003 Sep; 127(9):e378-81. PubMed ID: 12946212
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
[TBL] [Abstract][Full Text] [Related]
12. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.
Marx A; Ströbel P; Badve SS; Chalabreysse L; Chan JK; Chen G; de Leval L; Detterbeck F; Girard N; Huang J; Kurrer MO; Lauriola L; Marino M; Matsuno Y; Molina TJ; Mukai K; Nicholson AG; Nonaka D; Rieker R; Rosai J; Ruffini E; Travis WD
J Thorac Oncol; 2014 May; 9(5):596-611. PubMed ID: 24722150
[TBL] [Abstract][Full Text] [Related]
13. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma.
Kim BS; Kim JK; Kang CH; Kim YT; Jung KC; Won JK
Pathol Res Pract; 2018 Mar; 214(3):343-349. PubMed ID: 29487009
[TBL] [Abstract][Full Text] [Related]
16. Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma.
Asirvatham JR; Esposito MJ; Bhuiya TA
Appl Immunohistochem Mol Morphol; 2014; 22(5):372-6. PubMed ID: 23958552
[TBL] [Abstract][Full Text] [Related]
17. [Basaloid thymic carcinoma: report of two cases].
Li X; Xu RJ; Zhou H; Liu H
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):199-201. PubMed ID: 20450771
[No Abstract] [Full Text] [Related]
18. Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery.
Ito Y; Miyauchi A; Nakamura Y; Miya A; Kobayashi K; Kakudo K
Am J Clin Pathol; 2007 Feb; 127(2):230-6. PubMed ID: 17210519
[TBL] [Abstract][Full Text] [Related]
19. Orbital gastrointestinal stromal tumor metastasis.
Woo D; Leong J; Waring D; Sharma A; Martin P
Orbit; 2012 Apr; 31(2):129-31. PubMed ID: 22489857
[TBL] [Abstract][Full Text] [Related]
20. [Lung metastasis of thymic carcinoma twelve years after complete resection of primary disease].
Togashi K; Sato S; Sato K
Kyobu Geka; 2009 Dec; 62(13):1150-3. PubMed ID: 19999093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
